

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.79095521 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.79095521 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.58940057 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.58940057 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.79863545 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.62680124 |
| 7 | urea metabolic process (GO:0019627) | 5.25105662 |
| 8 | urea cycle (GO:0000050) | 5.25105662 |
| 9 | desmosome organization (GO:0002934) | 5.18862655 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 5.16213111 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06628966 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.03994217 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.00480994 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.00052281 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.00052281 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.00052281 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.97819876 |
| 18 | cysteine metabolic process (GO:0006534) | 4.82546640 |
| 19 | protein carboxylation (GO:0018214) | 4.74681445 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.74681445 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.73010105 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 4.72568676 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.69759789 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.66484045 |
| 25 | bile acid metabolic process (GO:0008206) | 4.61545340 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 4.58805347 |
| 27 | negative regulation of sterol transport (GO:0032372) | 4.58656816 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 4.58656816 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.53189559 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 4.51429787 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.49456380 |
| 32 | phospholipid efflux (GO:0033700) | 4.45816220 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.44654180 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.40141152 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.40141152 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40141152 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.35561913 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.33411298 |
| 39 | bile acid and bile salt transport (GO:0015721) | 4.31617724 |
| 40 | complement activation, alternative pathway (GO:0006957) | 4.27875561 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.26030653 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.23599434 |
| 43 | blood coagulation, intrinsic pathway (GO:0007597) | 4.23255858 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 4.21318582 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.18816109 |
| 46 | regulation of bile acid biosynthetic process (GO:0070857) | 4.18270414 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.17367892 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.17367892 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.16431445 |
| 50 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.15220443 |
| 51 | cellular glucuronidation (GO:0052695) | 4.14987442 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 4.11978713 |
| 53 | regulation of complement activation (GO:0030449) | 4.06881168 |
| 54 | cholesterol efflux (GO:0033344) | 3.97992745 |
| 55 | lysine metabolic process (GO:0006553) | 3.93922540 |
| 56 | lysine catabolic process (GO:0006554) | 3.93922540 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92486387 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.90132783 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.88908717 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 3.86318429 |
| 61 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83278985 |
| 62 | ethanol oxidation (GO:0006069) | 3.82119900 |
| 63 | drug catabolic process (GO:0042737) | 3.78939908 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.76567619 |
| 65 | cholesterol homeostasis (GO:0042632) | 3.76181053 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.76018918 |
| 67 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73231628 |
| 68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73231628 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.71556822 |
| 70 | sterol homeostasis (GO:0055092) | 3.70003826 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.69820673 |
| 72 | glycine metabolic process (GO:0006544) | 3.69763243 |
| 73 | intestinal absorption (GO:0050892) | 3.66287262 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.64130413 |
| 75 | uronic acid metabolic process (GO:0006063) | 3.63353119 |
| 76 | glucuronate metabolic process (GO:0019585) | 3.63353119 |
| 77 | phospholipid scrambling (GO:0017121) | 3.60571297 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 3.59995244 |
| 79 | glutamate metabolic process (GO:0006536) | 3.58367350 |
| 80 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.57187085 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 3.54766838 |
| 82 | positive regulation of lipid catabolic process (GO:0050996) | 3.54237041 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.54227451 |
| 84 | flavonoid metabolic process (GO:0009812) | 3.53402267 |
| 85 | phospholipid homeostasis (GO:0055091) | 3.53347813 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.52985571 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.52387667 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.51182019 |
| 89 | striated muscle atrophy (GO:0014891) | 3.50815458 |
| 90 | coenzyme catabolic process (GO:0009109) | 3.49525616 |
| 91 | response to nitrosative stress (GO:0051409) | 3.48375697 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.45793284 |
| 93 | fibrinolysis (GO:0042730) | 3.43714460 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.40679517 |
| 95 | ethanol metabolic process (GO:0006067) | 3.40347028 |
| 96 | amine catabolic process (GO:0009310) | 3.38826916 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 3.38826916 |
| 98 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.37974002 |
| 99 | protein-lipid complex subunit organization (GO:0071825) | 3.37896646 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.34145099 |
| 101 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.32993298 |
| 102 | arginine metabolic process (GO:0006525) | 3.32173787 |
| 103 | drug transmembrane transport (GO:0006855) | 3.28887992 |
| 104 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.26642819 |
| 105 | regulation of cholesterol metabolic process (GO:0090181) | 3.26524973 |
| 106 | negative regulation of protein activation cascade (GO:2000258) | 3.25573342 |
| 107 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.22032936 |
| 108 | regulation of apoptotic cell clearance (GO:2000425) | 3.21956182 |
| 109 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18270156 |
| 110 | intestinal epithelial cell development (GO:0060576) | 3.17950367 |
| 111 | organic acid catabolic process (GO:0016054) | 3.17620616 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.17620616 |
| 113 | endocardial cushion development (GO:0003197) | 3.16820034 |
| 114 | thrombin receptor signaling pathway (GO:0070493) | 3.13946247 |
| 115 | * receptor catabolic process (GO:0032801) | 3.10758866 |
| 116 | lung epithelium development (GO:0060428) | 3.04778463 |
| 117 | skeletal muscle adaptation (GO:0043501) | 3.02163947 |
| 118 | transepithelial transport (GO:0070633) | 3.01106959 |
| 119 | diacylglycerol metabolic process (GO:0046339) | 2.99289596 |
| 120 | proline metabolic process (GO:0006560) | 2.96659628 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 2.88771101 |
| 122 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.88485367 |
| 123 | proline biosynthetic process (GO:0006561) | 2.86904429 |
| 124 | muscle atrophy (GO:0014889) | 2.85783638 |
| 125 | negative regulation of myotube differentiation (GO:0010832) | 2.85287364 |
| 126 | negative regulation of complement activation (GO:0045916) | 2.84188604 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.83792088 |
| 128 | positive regulation of steroid metabolic process (GO:0045940) | 2.78120458 |
| 129 | trivalent inorganic anion homeostasis (GO:0072506) | 2.77743395 |
| 130 | phosphate ion homeostasis (GO:0055062) | 2.77743395 |
| 131 | protein activation cascade (GO:0072376) | 2.71980363 |
| 132 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.70857968 |
| 133 | regulation of extracellular matrix organization (GO:1903053) | 2.69411238 |
| 134 | complement activation, classical pathway (GO:0006958) | 2.67823090 |
| 135 | negative regulation of sodium ion transport (GO:0010766) | 2.66100047 |
| 136 | regulation of humoral immune response (GO:0002920) | 2.64534674 |
| 137 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.64346968 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.61564094 |
| 139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.59336296 |
| 140 | auditory receptor cell differentiation (GO:0042491) | 2.58471183 |
| 141 | positive regulation of hemostasis (GO:1900048) | 2.57741270 |
| 142 | positive regulation of blood coagulation (GO:0030194) | 2.57741270 |
| 143 | regulation of viral release from host cell (GO:1902186) | 2.57259411 |
| 144 | negative regulation of humoral immune response (GO:0002921) | 2.55514259 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.54879177 |
| 146 | regulation of water loss via skin (GO:0033561) | 2.54502786 |
| 147 | regulation of integrin activation (GO:0033623) | 2.53386958 |
| 148 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.51895580 |
| 149 | negative regulation of blood coagulation (GO:0030195) | 2.51348935 |
| 150 | negative regulation of hemostasis (GO:1900047) | 2.51348935 |
| 151 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.50423846 |
| 152 | inner ear receptor cell differentiation (GO:0060113) | 2.49700178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.51704945 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.82649722 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.18896834 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51352353 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.27612965 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.53837651 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.07261435 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.97834614 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.77296472 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.47577083 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.82082862 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72582286 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.23346044 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18693201 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02807411 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.01688850 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92557231 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90379565 |
| 19 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.83653673 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79947406 |
| 21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.78096971 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76730800 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73327598 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71934938 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.68812236 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58038042 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56753928 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56692221 |
| 29 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.51966965 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51027808 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50363769 |
| 32 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48023906 |
| 33 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.47087145 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39451918 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37726954 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36640038 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33583935 |
| 38 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.33080463 |
| 39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32129165 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31269017 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30875239 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30458447 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28348503 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26470851 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26049716 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24735478 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24573529 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22612619 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21510890 |
| 50 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20021443 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19524921 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19212822 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18945115 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15323647 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14927529 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13991132 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10329331 |
| 58 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.10322614 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10036897 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09273671 |
| 61 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08993503 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08644080 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07977589 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07859804 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07711500 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07512208 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06273299 |
| 68 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04695985 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04151777 |
| 70 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03290416 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01442097 |
| 72 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01205938 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00530394 |
| 74 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00319255 |
| 75 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98631762 |
| 76 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98391636 |
| 77 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96492393 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96377820 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96301487 |
| 80 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94940568 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94734730 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94267386 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94017886 |
| 84 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93732914 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93148066 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92907828 |
| 87 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90040842 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89512916 |
| 89 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87900722 |
| 90 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86864301 |
| 91 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83557137 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83263217 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83060825 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82577384 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82461945 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81693504 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79651643 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79651643 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79425936 |
| 100 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79360361 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78562471 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78163750 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77302267 |
| 104 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73336391 |
| 105 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.73241179 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71380948 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69800810 |
| 108 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69659837 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69585017 |
| 110 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.67427661 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.65633669 |
| 112 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65129957 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63981410 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63699910 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63160914 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61396096 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58771805 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58771805 |
| 119 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.58706172 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.58539456 |
| 121 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56407034 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55422407 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.54787121 |
| 124 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.54215900 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.53685499 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.53398329 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.53189349 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53006772 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52740487 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.52450397 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.52214517 |
| 132 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.52040580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.92604749 |
| 2 | MP0005360_urolithiasis | 6.74437292 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.64335704 |
| 4 | MP0005365_abnormal_bile_salt | 5.31306044 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.50285269 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.48967119 |
| 7 | MP0003252_abnormal_bile_duct | 3.41787008 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.17916998 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.02981811 |
| 10 | MP0009840_abnormal_foam_cell | 2.87564954 |
| 11 | MP0003123_paternal_imprinting | 2.74407865 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.73063932 |
| 13 | MP0005083_abnormal_biliary_tract | 2.72646596 |
| 14 | MP0002254_reproductive_system_inflammat | 2.24152086 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.19449076 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.15269674 |
| 17 | MP0005332_abnormal_amino_acid | 2.11985175 |
| 18 | MP0005409_darkened_coat_color | 2.05458947 |
| 19 | MP0005076_abnormal_cell_differentiation | 1.98838828 |
| 20 | MP0000609_abnormal_liver_physiology | 1.92863725 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.89391179 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.81002921 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.73258749 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.71657839 |
| 25 | MP0003195_calcinosis | 1.71102903 |
| 26 | MP0003868_abnormal_feces_composition | 1.69871316 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.65429068 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.54923997 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.51923958 |
| 30 | MP0002796_impaired_skin_barrier | 1.50922830 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.50374091 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.49160831 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.48073281 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.45041759 |
| 35 | MP0005310_abnormal_salivary_gland | 1.41060138 |
| 36 | MP0003122_maternal_imprinting | 1.40342309 |
| 37 | MP0001664_abnormal_digestion | 1.38812438 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.33554243 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.28814251 |
| 40 | MP0001873_stomach_inflammation | 1.28725497 |
| 41 | MP0005670_abnormal_white_adipose | 1.27926809 |
| 42 | MP0005451_abnormal_body_composition | 1.27676171 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.26830321 |
| 44 | MP0003943_abnormal_hepatobiliary_system | 1.25518749 |
| 45 | MP0004043_abnormal_pH_regulation | 1.22514513 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.18596199 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.18217379 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.13310436 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.11216120 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.10943894 |
| 51 | MP0001764_abnormal_homeostasis | 1.10890331 |
| 52 | MP0005408_hypopigmentation | 1.10550828 |
| 53 | MP0002060_abnormal_skin_morphology | 1.10156754 |
| 54 | MP0002006_tumorigenesis | 1.07999332 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.07798940 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07271311 |
| 57 | MP0000579_abnormal_nail_morphology | 1.06354962 |
| 58 | MP0000462_abnormal_digestive_system | 1.06349437 |
| 59 | MP0002098_abnormal_vibrissa_morphology | 1.05393748 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.05312837 |
| 61 | MP0004947_skin_inflammation | 1.03435312 |
| 62 | MP0000383_abnormal_hair_follicle | 1.02599118 |
| 63 | MP0000858_altered_metastatic_potential | 1.02133163 |
| 64 | MP0005666_abnormal_adipose_tissue | 0.99821996 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.99752493 |
| 66 | MP0000566_synostosis | 0.98309627 |
| 67 | MP0000598_abnormal_liver_morphology | 0.96395445 |
| 68 | MP0000490_abnormal_crypts_of | 0.95496951 |
| 69 | MP0001216_abnormal_epidermal_layer | 0.94858410 |
| 70 | MP0009764_decreased_sensitivity_to | 0.94362679 |
| 71 | MP0000537_abnormal_urethra_morphology | 0.92021338 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.91991377 |
| 73 | MP0000678_abnormal_parathyroid_gland | 0.89921872 |
| 74 | MP0002009_preneoplasia | 0.88783163 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.87914660 |
| 76 | MP0004381_abnormal_hair_follicle | 0.87042066 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.85932842 |
| 78 | MP0009763_increased_sensitivity_to | 0.85872527 |
| 79 | MP0003315_abnormal_perineum_morphology | 0.85052087 |
| 80 | MP0001849_ear_inflammation | 0.84927326 |
| 81 | MP0005647_abnormal_sex_gland | 0.84442423 |
| 82 | MP0002396_abnormal_hematopoietic_system | 0.84101877 |
| 83 | MP0001881_abnormal_mammary_gland | 0.83848792 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.83755254 |
| 85 | MP0009053_abnormal_anal_canal | 0.83015675 |
| 86 | MP0005501_abnormal_skin_physiology | 0.81977679 |
| 87 | MP0000604_amyloidosis | 0.80719169 |
| 88 | MP0000377_abnormal_hair_follicle | 0.79546930 |
| 89 | MP0008469_abnormal_protein_level | 0.78736743 |
| 90 | MP0009697_abnormal_copulation | 0.78119245 |
| 91 | MP0005025_abnormal_response_to | 0.77416631 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.77169859 |
| 93 | MP0001270_distended_abdomen | 0.76658080 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.76221283 |
| 95 | MP0003879_abnormal_hair_cell | 0.75337287 |
| 96 | MP0002132_abnormal_respiratory_system | 0.75258692 |
| 97 | MP0009115_abnormal_fat_cell | 0.74991399 |
| 98 | MP0001800_abnormal_humoral_immune | 0.74719918 |
| 99 | MP0003866_abnormal_defecation | 0.73734866 |
| 100 | MP0001663_abnormal_digestive_system | 0.73210384 |
| 101 | MP0003186_abnormal_redox_activity | 0.72214256 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.71813527 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.70009919 |
| 104 | MP0005448_abnormal_energy_balance | 0.69929853 |
| 105 | MP0001835_abnormal_antigen_presentation | 0.69236932 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.68019156 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.67616990 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.67113595 |
| 109 | MP0002086_abnormal_extraembryonic_tissu | 0.67103831 |
| 110 | MP0000470_abnormal_stomach_morphology | 0.66939915 |
| 111 | MP0005023_abnormal_wound_healing | 0.66848379 |
| 112 | MP0003011_delayed_dark_adaptation | 0.66832529 |
| 113 | MP0002970_abnormal_white_adipose | 0.65532373 |
| 114 | MP0000467_abnormal_esophagus_morphology | 0.65280292 |
| 115 | MP0002933_joint_inflammation | 0.64788600 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.64008198 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.63594999 |
| 118 | MP0000685_abnormal_immune_system | 0.62280105 |
| 119 | MP0000613_abnormal_salivary_gland | 0.61683777 |
| 120 | MP0001243_abnormal_dermal_layer | 0.59410428 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.58633941 |
| 122 | MP0000647_abnormal_sebaceous_gland | 0.58539519 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.58323172 |
| 124 | MP0000427_abnormal_hair_cycle | 0.58094193 |
| 125 | MP0008872_abnormal_physiological_respon | 0.57925889 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.56365251 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.56352131 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.56150320 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.55272037 |
| 130 | MP0010771_integument_phenotype | 0.54026293 |
| 131 | MP0005166_decreased_susceptibility_to | 0.53350126 |
| 132 | MP0008004_abnormal_stomach_pH | 0.51905411 |
| 133 | MP0005084_abnormal_gallbladder_morpholo | 0.51885882 |
| 134 | MP0009931_abnormal_skin_appearance | 0.49843024 |
| 135 | MP0001756_abnormal_urination | 0.49596912 |
| 136 | MP0003436_decreased_susceptibility_to | 0.48202513 |
| 137 | MP0003724_increased_susceptibility_to | 0.47462819 |
| 138 | MP0000627_abnormal_mammary_gland | 0.45434687 |
| 139 | MP0001853_heart_inflammation | 0.44972398 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.44684966 |
| 141 | MP0006082_CNS_inflammation | 0.44463204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.93018590 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.47940706 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.42838187 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.17707266 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.76027393 |
| 6 | Xanthomatosis (HP:0000991) | 5.54800239 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.36242475 |
| 8 | Prolonged bleeding time (HP:0003010) | 4.63386940 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38130545 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.30460392 |
| 11 | Fat malabsorption (HP:0002630) | 4.29810814 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.22596827 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.17028079 |
| 14 | Flat acetabular roof (HP:0003180) | 4.12566199 |
| 15 | Complement deficiency (HP:0004431) | 4.12501185 |
| 16 | Hyperammonemia (HP:0001987) | 4.11527417 |
| 17 | Purpura (HP:0000979) | 4.02625917 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.96736032 |
| 19 | Epidermoid cyst (HP:0200040) | 3.87789329 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78209385 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.72960121 |
| 22 | Joint hemorrhage (HP:0005261) | 3.59213222 |
| 23 | Abnormal tarsal ossification (HP:0008369) | 3.58549000 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51936891 |
| 25 | Hyperglycinemia (HP:0002154) | 3.50515228 |
| 26 | Ketosis (HP:0001946) | 3.45820036 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.44666437 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.44666437 |
| 29 | Hyperglycinuria (HP:0003108) | 3.43583995 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.43054118 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.36428231 |
| 32 | Ileus (HP:0002595) | 3.35734865 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 3.32380198 |
| 34 | Abnormality of carpal bone ossification (HP:0006257) | 3.31786866 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.30340745 |
| 36 | Vascular calcification (HP:0004934) | 3.29331141 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.15292294 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.12083729 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.11281901 |
| 40 | Steatorrhea (HP:0002570) | 3.09062181 |
| 41 | Abnormality of complement system (HP:0005339) | 3.04682527 |
| 42 | Myocardial infarction (HP:0001658) | 3.03140695 |
| 43 | Malnutrition (HP:0004395) | 3.01505926 |
| 44 | Abnormal platelet volume (HP:0011876) | 3.01153883 |
| 45 | Epistaxis (HP:0000421) | 2.96725503 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.94684553 |
| 47 | Acanthocytosis (HP:0001927) | 2.91573514 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.90971420 |
| 49 | Onycholysis (HP:0001806) | 2.86131142 |
| 50 | Abnormality of the gastric mucosa (HP:0004295) | 2.80373770 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76296091 |
| 52 | Abnormality of the nasal septum (HP:0000419) | 2.76059791 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74951522 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.74794298 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.74279237 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.73720769 |
| 57 | Esophageal varix (HP:0002040) | 2.73350443 |
| 58 | Abnormal hand bone ossification (HP:0010660) | 2.67117943 |
| 59 | Abnormal ossification of hand bones (HP:0005921) | 2.62307652 |
| 60 | Abnormal foot bone ossification (HP:0010675) | 2.59837779 |
| 61 | Spastic diplegia (HP:0001264) | 2.57828940 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.51315501 |
| 63 | Small epiphyses (HP:0010585) | 2.49561220 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.46279511 |
| 65 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.46107176 |
| 66 | Asymmetry of the thorax (HP:0001555) | 2.45841703 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.45540507 |
| 68 | Septate vagina (HP:0001153) | 2.44007113 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.43860476 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.42222091 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.42222091 |
| 72 | Metabolic acidosis (HP:0001942) | 2.40856123 |
| 73 | Gout (HP:0001997) | 2.39376470 |
| 74 | Hyperactive renin-angiotensin system (HP:0000841) | 2.38651443 |
| 75 | Milia (HP:0001056) | 2.38448534 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.34428300 |
| 77 | Colitis (HP:0002583) | 2.33776608 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 2.33380498 |
| 79 | Ketoacidosis (HP:0001993) | 2.32897483 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.30065712 |
| 81 | Cholelithiasis (HP:0001081) | 2.28909614 |
| 82 | Oligodontia (HP:0000677) | 2.23793331 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.23068160 |
| 84 | Gingival bleeding (HP:0000225) | 2.21733948 |
| 85 | Cheilitis (HP:0100825) | 2.19958450 |
| 86 | Micronodular cirrhosis (HP:0001413) | 2.19589387 |
| 87 | Delayed CNS myelination (HP:0002188) | 2.18349705 |
| 88 | Petechiae (HP:0000967) | 2.17973988 |
| 89 | Spontaneous abortion (HP:0005268) | 2.17095539 |
| 90 | Pancreatitis (HP:0001733) | 2.15574453 |
| 91 | Pili torti (HP:0003777) | 2.14685469 |
| 92 | Amyloidosis (HP:0011034) | 2.11845075 |
| 93 | Poikilocytosis (HP:0004447) | 2.10520743 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 2.08006154 |
| 95 | Plantar hyperkeratosis (HP:0007556) | 2.07997640 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.06126327 |
| 97 | Lethargy (HP:0001254) | 2.05497139 |
| 98 | Joint swelling (HP:0001386) | 2.03956900 |
| 99 | Seborrheic dermatitis (HP:0001051) | 2.01775736 |
| 100 | Broad alveolar ridges (HP:0000187) | 2.01570593 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01363485 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.01363485 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01027029 |
| 104 | Abnormality of chloride homeostasis (HP:0011422) | 1.99820483 |
| 105 | Broad palm (HP:0001169) | 1.99671528 |
| 106 | Villous atrophy (HP:0011473) | 1.98923690 |
| 107 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.98923690 |
| 108 | Rectal prolapse (HP:0002035) | 1.98028725 |
| 109 | Increased mean platelet volume (HP:0011877) | 1.97270370 |
| 110 | Pustule (HP:0200039) | 1.97155938 |
| 111 | Autoimmune hemolytic anemia (HP:0001890) | 1.96980188 |
| 112 | Rickets (HP:0002748) | 1.96802482 |
| 113 | Fragile nails (HP:0001808) | 1.96227560 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.96050102 |
| 115 | Abnormal platelet function (HP:0011869) | 1.96050102 |
| 116 | Amelogenesis imperfecta (HP:0000705) | 1.95859312 |
| 117 | Abdominal distention (HP:0003270) | 1.95837497 |
| 118 | Menorrhagia (HP:0000132) | 1.95653879 |
| 119 | Skin nodule (HP:0200036) | 1.92742234 |
| 120 | Abnormal hair laboratory examination (HP:0003328) | 1.91673452 |
| 121 | Decreased circulating renin level (HP:0003351) | 1.88794124 |
| 122 | Late onset (HP:0003584) | 1.88005114 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.87008931 |
| 124 | Ridged nail (HP:0001807) | 1.86884392 |
| 125 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86525981 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86041006 |
| 127 | Curly hair (HP:0002212) | 1.85565171 |
| 128 | Hyponatremia (HP:0002902) | 1.84594177 |
| 129 | Renal cortical cysts (HP:0000803) | 1.83742903 |
| 130 | Chronic diarrhea (HP:0002028) | 1.82500935 |
| 131 | Atrophic scars (HP:0001075) | 1.81968800 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.80413610 |
| 133 | Cholecystitis (HP:0001082) | 1.80413610 |
| 134 | Irritability (HP:0000737) | 1.79884646 |
| 135 | Brushfield spots (HP:0001088) | 1.79658045 |
| 136 | Thrombophlebitis (HP:0004418) | 1.79087480 |
| 137 | Periodontitis (HP:0000704) | 1.78816298 |
| 138 | Opisthotonus (HP:0002179) | 1.78567021 |
| 139 | Hypoglycemic seizures (HP:0002173) | 1.77311779 |
| 140 | Abnormality of vitamin metabolism (HP:0100508) | 1.76738866 |
| 141 | Systemic lupus erythematosus (HP:0002725) | 1.76359358 |
| 142 | Gastrointestinal infarctions (HP:0005244) | 1.76040673 |
| 143 | Abnormal cartilage morphology (HP:0002763) | 1.75885487 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.75804877 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 1.75175150 |
| 146 | Leiomyosarcoma (HP:0100243) | 1.75135257 |
| 147 | Uterine leiomyosarcoma (HP:0002891) | 1.75135257 |
| 148 | Hypophosphatemic rickets (HP:0004912) | 1.74270916 |
| 149 | Woolly hair (HP:0002224) | 1.74047430 |
| 150 | Glomerulonephritis (HP:0000099) | 1.73448767 |
| 151 | Epiphyseal dysplasia (HP:0002656) | 1.73383282 |
| 152 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72977519 |
| 153 | Glomerulosclerosis (HP:0000096) | 1.72459683 |
| 154 | Renal cell carcinoma (HP:0005584) | 1.72057508 |
| 155 | Nephritis (HP:0000123) | 1.71677841 |
| 156 | Coarse hair (HP:0002208) | 1.71592140 |
| 157 | Reticulocytosis (HP:0001923) | 1.71113487 |
| 158 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.69688526 |
| 159 | Neonatal death (HP:0003811) | 1.68577858 |
| 160 | Abnormality of the wing of the ilium (HP:0011867) | 1.68334024 |
| 161 | Gastrointestinal carcinoma (HP:0002672) | 1.68075983 |
| 162 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.68075983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 4.11416670 |
| 2 | EPHA2 | 3.44016100 |
| 3 | ERN1 | 3.40565586 |
| 4 | BCKDK | 3.39544146 |
| 5 | FGFR4 | 3.24819082 |
| 6 | MST1R | 2.91805420 |
| 7 | TAOK3 | 2.81396090 |
| 8 | FRK | 2.78980645 |
| 9 | LATS1 | 2.49050144 |
| 10 | MST4 | 2.41328532 |
| 11 | WNK4 | 2.39169421 |
| 12 | PTK6 | 2.35691229 |
| 13 | LMTK2 | 2.32843160 |
| 14 | EPHB1 | 2.19907767 |
| 15 | PKN2 | 1.89383191 |
| 16 | ICK | 1.82708683 |
| 17 | MAPK15 | 1.79990845 |
| 18 | TYK2 | 1.72961049 |
| 19 | MAP2K2 | 1.71603820 |
| 20 | TRIB3 | 1.65360254 |
| 21 | FGFR2 | 1.61238259 |
| 22 | NUAK1 | 1.54902231 |
| 23 | RIPK1 | 1.54580831 |
| 24 | MAPKAPK3 | 1.54324750 |
| 25 | MET | 1.41766015 |
| 26 | SMG1 | 1.41579793 |
| 27 | JAK1 | 1.40208077 |
| 28 | GRK6 | 1.39544178 |
| 29 | MAP4K1 | 1.37370602 |
| 30 | EEF2K | 1.36242985 |
| 31 | MAP3K10 | 1.36241518 |
| 32 | STK10 | 1.33848514 |
| 33 | MAP3K14 | 1.30510887 |
| 34 | STK39 | 1.25786696 |
| 35 | STK24 | 1.25134934 |
| 36 | ERBB2 | 1.24021424 |
| 37 | PTK2 | 1.23221108 |
| 38 | ERBB4 | 1.22813080 |
| 39 | MAP3K7 | 1.19772399 |
| 40 | ACVR1B | 1.16380839 |
| 41 | MAP3K3 | 1.14936676 |
| 42 | TBK1 | 1.12869963 |
| 43 | RIPK4 | 1.12734900 |
| 44 | LRRK2 | 1.12017786 |
| 45 | CDK6 | 1.09839522 |
| 46 | FER | 1.07181532 |
| 47 | MAP3K2 | 1.06878035 |
| 48 | CDC42BPA | 1.02011422 |
| 49 | MAP2K6 | 0.97898442 |
| 50 | MAPK11 | 0.97444998 |
| 51 | IKBKE | 0.95680952 |
| 52 | EPHA3 | 0.95583008 |
| 53 | JAK2 | 0.95045464 |
| 54 | INSRR | 0.93509400 |
| 55 | ITK | 0.92612236 |
| 56 | RPS6KB2 | 0.92156149 |
| 57 | DYRK1B | 0.88943366 |
| 58 | PRKG2 | 0.88894623 |
| 59 | CSK | 0.85914835 |
| 60 | PRKAA2 | 0.85243730 |
| 61 | AKT3 | 0.84673505 |
| 62 | TYRO3 | 0.82730375 |
| 63 | TNK2 | 0.82453970 |
| 64 | PDPK1 | 0.82232396 |
| 65 | IRAK3 | 0.77805082 |
| 66 | SCYL2 | 0.77614014 |
| 67 | CHUK | 0.76955602 |
| 68 | EPHB2 | 0.76543410 |
| 69 | CAMK1D | 0.75638456 |
| 70 | BMX | 0.74142930 |
| 71 | EIF2AK1 | 0.74141884 |
| 72 | ZAP70 | 0.71785023 |
| 73 | PRKCQ | 0.71120155 |
| 74 | PDK1 | 0.70714523 |
| 75 | MELK | 0.69529409 |
| 76 | JAK3 | 0.67373074 |
| 77 | GSK3A | 0.67071583 |
| 78 | PIK3CG | 0.62691511 |
| 79 | NEK9 | 0.61445977 |
| 80 | TESK2 | 0.60309210 |
| 81 | FGFR3 | 0.60249579 |
| 82 | NLK | 0.59873625 |
| 83 | DDR2 | 0.58302810 |
| 84 | PBK | 0.57959988 |
| 85 | STK3 | 0.57271178 |
| 86 | FGR | 0.56842023 |
| 87 | WNK1 | 0.55035252 |
| 88 | IRAK4 | 0.49519016 |
| 89 | TRPM7 | 0.48928031 |
| 90 | MAP2K1 | 0.48831365 |
| 91 | CSNK1A1L | 0.48800839 |
| 92 | TXK | 0.47953528 |
| 93 | CAMK2G | 0.46781746 |
| 94 | PDGFRB | 0.45991101 |
| 95 | CSNK1G1 | 0.45842564 |
| 96 | STK38L | 0.44985826 |
| 97 | MAP3K11 | 0.44855929 |
| 98 | PRKCI | 0.44293674 |
| 99 | CDK7 | 0.43215613 |
| 100 | MAP2K3 | 0.43169541 |
| 101 | PIK3CA | 0.42899115 |
| 102 | MARK2 | 0.42312198 |
| 103 | PRKAA1 | 0.42161427 |
| 104 | NEK6 | 0.41989131 |
| 105 | TAOK1 | 0.41314316 |
| 106 | HIPK2 | 0.39796103 |
| 107 | RPS6KB1 | 0.39727138 |
| 108 | FLT3 | 0.38624578 |
| 109 | GRK1 | 0.38116415 |
| 110 | MAP3K1 | 0.37585439 |
| 111 | PRKCZ | 0.36948742 |
| 112 | SYK | 0.36892092 |
| 113 | IKBKB | 0.36389360 |
| 114 | MAPKAPK2 | 0.33849576 |
| 115 | NME1 | 0.33246781 |
| 116 | YES1 | 0.33123370 |
| 117 | STK38 | 0.32963193 |
| 118 | CDK12 | 0.32874755 |
| 119 | PDGFRA | 0.32527590 |
| 120 | MTOR | 0.32509267 |
| 121 | BTK | 0.32377285 |
| 122 | MAPK4 | 0.32227288 |
| 123 | SIK2 | 0.31800086 |
| 124 | SGK3 | 0.31702655 |
| 125 | PAK4 | 0.31689501 |
| 126 | BMPR2 | 0.31505455 |
| 127 | TGFBR2 | 0.31369422 |
| 128 | KDR | 0.31147980 |
| 129 | FGFR1 | 0.30751432 |
| 130 | MATK | 0.30743642 |
| 131 | CDK4 | 0.30610429 |
| 132 | PRKD1 | 0.30121306 |
| 133 | CSF1R | 0.30095612 |
| 134 | MAP2K4 | 0.29070381 |
| 135 | OXSR1 | 0.29020259 |
| 136 | RET | 0.28734739 |
| 137 | CAMK1G | 0.26359967 |
| 138 | LCK | 0.25884224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.04143742 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.75995781 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70975067 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79003286 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69541460 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54698485 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.47756364 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45064154 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41135302 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30739169 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28911402 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28853703 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26872759 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25756793 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.25274459 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21283036 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03666516 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00355766 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99174571 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.95595634 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94038798 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80688374 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77711409 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.76977126 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74924028 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71203475 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64317898 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.63854004 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62561658 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59965287 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59399296 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.46868957 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45886335 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43622576 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42615567 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40907201 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40801778 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39186673 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.37776219 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37502567 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30867631 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30589313 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22065415 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21232184 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16702694 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16032024 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14796041 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13953870 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11480657 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10733440 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10379648 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09159460 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02688782 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00699660 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00494973 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99495779 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98810262 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97252794 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97012584 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95312782 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95050748 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91492871 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90552774 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90031768 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89762948 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.89160838 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.88326894 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85837613 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85106940 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73434801 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72438362 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72380295 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72159309 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72107989 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72019086 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70946312 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70805064 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67046384 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65135630 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64072371 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63520043 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63032150 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59947122 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59607359 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59095791 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58740165 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56025005 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54959758 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54874789 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54101995 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53542696 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51283041 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51274353 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49603955 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46934476 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46678349 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.45853034 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44837875 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.42477080 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42240248 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40194104 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37026076 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.35330668 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33939544 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32835740 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32308635 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30595922 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.30198390 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29577036 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25509117 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20795110 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.19476449 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17191216 |
| 114 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14125369 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.12255318 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10411112 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06153909 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04927910 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.03528834 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.03191964 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.03065742 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02277475 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01758288 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.01725457 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.01299098 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.00228245 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00147244 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00038557 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0681214 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0566185 |
| 131 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0294301 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0234032 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0224056 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0146519 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0129117 |

